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For the past twenty years, many scientific papers on
malaria have begun with statements such as 'there are an
estimated three billion people at risk of the disease'; or
'300–600 million episodes of clinical falciparum malaria
occur each year, killing between one and three million
individuals annually'; or 'the global burden of malaria
exceeds 40 million disability-adjusted life years' [1,2].
These figures may once have been a credible approxima-
tion, but need to be looked at today with considerable
scepticism, even when they appear in official statements.
Indeed, figures of malaria incidence/prevalence or of dis-
ease burden, are mostly based on reports of 'presumptive
diagnosis', the accuracy of which is 50% at best and less
than 5% in situations of low endemicity. Figures relating
to malaria mortality are even less reliable, because the
exact cause of death is always difficult to determine, even
in hospital settings [3]. Recent studies of severe malaria in
children in Malawi and in Kenya suggest that, in at least
25% of cases, the WHO definition of severe malaria is
unable to exclude concomitant bacterial or viral infec-
tions, which may actually be responsible for the fatal out-
come [4]. The field reality is worse, when one considers
that many malaria cases occur in remote areas, where the
resources for making adequate diagnosis are not available.
However, a general pattern is emerging, based on recent
publications and public statements and despite this inad-
equacy of the baseline figures, that malaria incidence is
decreasing worldwide and, in some cases, this has actually
been documented by reliable data. For example, child
mortality on the Kenyan coast has been reduced [5], and,
over the past few years, there has been a fall of 50–75% in
malaria incidence in Zanzibar [6], Eritrea [7], Ethiopia
and Rwanda [8]. Interestingly, there have been reports
from travel clinics in Europe indicating a reduction in
their imported malaria cases [9,10]. Policy-makers are
keen to believe that this reduction of malaria cases and of
malaria mortality is the result of their activity and the
mass interventions that have been made possible through
unprecedented funding for malaria control. An estimated
US$1.5 billion was spent in 2007, 47% of which was dis-
bursed by international donor agencies, including the
Global Fund [11]. Existing control measures, including
large-scale distribution of insecticide-impregnated bed
nets, improved diagnosis using rapid tests, treatment
using a combination of effective drugs including artemisi-
nin, and prevention/treatment of high-risk target groups
such as pregnant women, are known to work and will
undoubtedly have had an impact when implemented on
an operational scale in some endemic areas. However, a
decrease of malaria incidence has not always followed
implementation of control measures and other factors,
both human and climatic, may have also played a part.
Nevertheless, the decreasing pattern of incidence is
encouraging and, by giving funding agencies a first
impression of success, it has helped enormously in the
advocacy for further increases in the global funding effort,
which are considered necessary to achieve malaria con-
trol. As a result, Bill and Melinda Gates surprised the
malaria community in October 2007 by expressing their
firm commitment to global 'malaria eradication' [12]. This
was a bold statement, since the word 'eradication' had not
been used in official statements since the early 1970s,
when the failure of an earlier global eradication attempt
was recognized. The statement has had three noticeable
effects: (i) almost immediately, other agencies, hitherto
committed to control, jumped on the eradication band
wagon, (ii) it put the goal of 'elimination', if not yet of
'eradication', on the global agenda with a notional target
date of 2025, and (iii) the notion of elimination by 2025
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captured the imagination of the scientific community
working on malaria, which moved in a short space of time
from a realistic awareness of the enormity of the complex
and seemingly insoluble problem of malaria control to
cautious optimism that elimination by 2025 is a real pos-
sibility – the Emperor's New Clothes, perhaps?
Nobody believes that elimination will be easy to achieve
and it will undoubtedly require sustained, high level
funding and political commitment for many years.
Indeed, history shows that the single most important
cause of failure of the 1960s eradication campaign was the
rapid loss of political commitment once control had been
shown to work. The move from control to elimination is
actually a quantum leap. If it were once possible to state
that all the tools for control were available and that no fur-
ther research was required, it is doubtful whether elimina-
tion could be achieved with those same tools. There is
now a need to define a new research agenda and to iden-
tify the differences between control and elimination.
Malaria Journal is now in its seventh year of existence and
it has become a major journal in the discipline, reporting
on all aspects of malaria, 'from the bench, to the bedside
and to the bush'. There will no doubt be many papers
published on malaria elimination in the future, but it is
fitting that Malaria Journal should be the first journal to
publish a series of review articles looking at the many
aspects of the research agenda for malaria elimination on
a global scale.
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